Canada markets closed

Veritas Pharma Inc. (VRT.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.15000.0000 (0.00%)
At close: 2:28PM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 52.5M
Enterprise Value 32.59M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.06
52-Week Change 33.45%
S&P500 52-Week Change 331.46%
52 Week High 30.1950
52 Week Low 30.0900
50-Day Moving Average 30.1500
200-Day Moving Average 30.1500

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 516.69M
Implied Shares Outstanding 6N/A
Float 12.48M
% Held by Insiders 138.14%
% Held by Institutions 10.00%
Shares Short (Aug. 13, 2020) 4101
Short Ratio (Aug. 13, 2020) 40.01
Short % of Float (Aug. 13, 2020) 4N/A
Short % of Shares Outstanding (Aug. 13, 2020) 40.00%
Shares Short (prior month Jun. 29, 2020) 473

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Feb. 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Apr. 29, 2020
Most Recent Quarter (mrq)Jan. 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-4,124.69%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-880.43k
Diluted EPS (ttm)-0.0570
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)498
Total Cash Per Share (mrq)0
Total Debt (mrq)85k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.00
Book Value Per Share (mrq)-0.07

Cash Flow Statement

Operating Cash Flow (ttm)-103.65k
Levered Free Cash Flow (ttm)-478.62k